What is the best index of glycemic control in patients with diabetes mellitus on hemodialysis?

Japanese Journal of Nephrology

Volumn 38, Issue 7, 1996, Pages 305-308

  Ichikawa, Haruo ^a   Nagake, Yoshio ^a   Takahashi, Maki ^a   Nakazono, Hiroshi ^a   Kawabata, Kenji ^a   Shikata, Kenichi ^a   Makino, Hirofumi ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

1,5 anhydroglucitol; Diabetes mellitus; Fructosamine; Glycated albumin; Glycosylated hemoglobin; Hemodialysis; Index of glycemic control

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

AGED; ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; METABOLISM; MIDDLE AGED; RENAL REPLACEMENT THERAPY;

AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 0030187387     PISSN: 03852385     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Eschbach JW Jr., Funk D, Adamson J, Kuhn I, Scribner BH, Finch CA: Erythropoiesis in patients with renal failure undergoing chronic dialysis. N Engl J Med 276: 653-658, 1967
2. Boer MJ, Micdema K, Casparie AF: Glycosylated haemoglobin in renal failure. Diabctologia 18: 437-440, 1980
3. Dandona P, Freedman D, Moorhead JF: Glycosylated haemoglobin in chronic renal failure. Br Med J 1: 1183-1184, 1979
4. Emoto M, Tabata T, Inouc T, Nishizawa Y, Morii H: Plasma 1,5-anhydroglucitol concentration in patients with end-stage renal disease with and without diabetes mellitus. Nephron 61: 181-186, 1992
5. Hill RP, Hindle EJ, Howey JEA, Lemon M, Lloyd DR: Recommendations for adopting standard conditions and analytical procedures in the measurement of serum fruciosamine concentration. Ann Clin Biochem 27: 413-424, 1990
6. Howey JEA, Browning MCK, Fraser CG: Assay of serum fructosamine that minimizes standardization and matrix problems: use to assess components of biological variation. Clin Chem 33: 269-272, 1987
7. Lamb E, Venton TR, Cattell WR, Dawnay A: Serum glycated albumin and fructosamine in renal dialysis patients. Nephron 64: 82-88, 1993
8. Shima K, Ito N, Abe F, Hirota M, Yano M, Yamamoto Y, Uchida T, Noguchi K: High-performance liquid Chromatographic assay of serum glycated albumin. Diabetologia 31: 627-631, 1988
9. Abe F, Yano M, Hirota M, Ito N, Yoshioka H, Shima K: High-performance liquid Chromatographic assay of scrum glycated albumin, with special reference to a comparison of assay conditions with those of fructosamine. J Japan Diab Soc 32: 183-188, 1989 (in Japanese)
10. Kanda T, Nakamura M, Iwasaki M, Wada M, Kurotobi M, Shimizu Y: Clinical significance of HbAlc. serum fructosamine and 1,5-AG in diabetic patients complicated with liver cirrhosis. J Japan Diab Soc 36: 847-854, 1993 (in Japanese)
11. Yabuuchi M, Masuda M, Katoh K, Nakamura T, Akanuma H: Simple enzymatic method for determining 1,5-anhydro-D-glucitol in plasma for diagnosis of diabetes mellitus. Clin Chem 35: 2039-2043, 1989
12. Johnson RN, Metcalf PA, Baker JR: Fructosamine: a new approach to the estimation of serum glycosylprotein. An index of diabetic control. Clin Chim Acta 127: 87-95, 1982
13. Oimoi M, Masuta S, Sakai M, Ohara T, Hata F, Baba S: Influence of serum protein levels on serum fructosamine levels. Jpn J Med 28: 312-315, 1989
14. Ohno A, Ito H, Yokozcki K, Kashima T, Iric Y: Effect of recombinant human crythropoietin therapy on HbAlc in diabetic patients undergoing hemodialysis. J Jpn Dial Ther Soc 26: 1531-1534, 1993 (in Japanese)